Grantham, Mayo, Van Otterloo & Co (GMO)
NTR icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Nutrien NTR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2M Buy
440,818
+88,477
+25% +$6.31M 0.09% 109
2025
Q4 		$21.7M Sell
352,341
-78,553
-18% -$4.62M 0.06% 165
2025
Q3 		$25.3M Buy
430,894
+82,525
+24% +$4.81M 0.07% 145
2025
Q2 		$20.3M Sell
348,369
-338,885
-49% -$19.1M 0.06% 176
2025
Q1 		$34.1M Sell
687,254
-229,307
-25% -$11.7M 0.11% 125
2024
Q4 		$41M Sell
916,561
-8,579
-0.9% -$407K 0.13% 97
2024
Q3 		$44.5M Buy
925,140
+464,959
+101% +$22.4M 0.14% 99
2024
Q2 		$23.4M Buy
460,181
+122,042
+36% +$6.68M 0.08% 167
2024
Q1 		$18.4M Sell
338,139
-88,849
-21% -$4.63M 0.07% 197
2023
Q4 		$24.1M Sell
426,988
-466,808
-52% -$26.4M 0.11% 146
2023
Q3 		$55.3M Sell
893,796
-21,500
-2% -$1.36M 0.26% 68
2023
Q2 		$54.1M Buy
915,296
+68,395
+8% +$4.35M 0.25% 72
2023
Q1 		$62.5M Sell
846,901
-78,700
-9% -$6.07M 0.32% 57
2022
Q4 		$67.6M Sell
925,601
-23,365
-2% -$1.85M 0.36% 51
2022
Q3 		$79.2M Buy
948,966
+58,915
+7% +$5.07M 0.46% 48
2022
Q2 		$70.9M Sell
890,051
-28,066
-3% -$2.73M 0.38% 53
2022
Q1 		$95.4M Buy
918,117
+432,603
+89% +$35.8M 0.46% 43
2021
Q4 		$36.5M Buy
485,514
+176,779
+57% +$12.4M 0.18% 92
2021
Q3 		$20M Sell
308,735
-18,969
-6% -$1.16M 0.1% 174
2021
Q2 		$19.9M Sell
327,704
-30,495
-9% -$1.8M 0.1% 171
2021
Q1 		$19.3M Sell
358,199
-1,900
-0.5% -$103K 0.11% 155
2020
Q4 		$17.3M Sell
360,099
-9,300
-3% -$411K 0.11% 135
2020
Q3 		$14.5M Buy
369,399
+59,500
+19% +$2.17M 0.1% 122
2020
Q2 		$9.95M Buy
+309,899
New +$10.8M 0.07% 155
2019
Q1 		– Sell
-96,233
Closed -$4.52M – 730
2018
Q4 		$4.52M Buy
96,233
+600
+0.6% +$31.3K 0.04% 200
2018
Q3 		$5.52M Buy
95,633
+7,000
+8% +$387K 0.04% 193
2018
Q2 		$4.82M Buy
88,633
+33,900
+62% +$1.68M 0.03% 218
2018
Q1 		$2.59M Buy
+54,733
New +$2.74M 0.02% 292

Other funds holding NTR

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NTR Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Nutrien (NTR) stake by 25% in Q1 2026, buying an estimated $6.31M and bringing the position to 440,818 shares worth $33.2M. The position accounts for 0.09% of the portfolio, ranked #109.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NTR in Q1 2018 and has held it in 28 quarters since. The position peaked at $95.4M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 440,818 shares of Nutrien worth $33.2M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 88,477 Nutrien shares in Q1 2026, an estimated $6.31M.
  • Nutrien made up 0.09% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #109 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nutrien in Q1 2018 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nutrien position peaked at $95.4M in Q1 2022.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.